Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia Research Letter


Authors: Rossoff, J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Phillips, C. L.; Stefanski, H.; Talano, J. A.; Moskop, A.; Margossian, S. P.; Verneris, M. R.; Myers, G. D.; Karras, N.; Brown, P. A.; Qayed, M.; Hermiston, M.; Satwani, P.; Krupski, C.; Keating, A. K.; Wilcox, R.; Rabik, C. A.; Fabrizio, V. A.; Kunicki, M.; Chinnabhandar, V.; Goksenin, A. Y.; Curran, K. J.; Mackall, C. L.; Laetsch, T. W.; Schultz, L. M.
Title: Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia
Journal Title: Blood
Volume: 138
Issue: 21
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-25
Start Page: 2138
End Page: 2142
Language: English
DOI: 10.1182/blood.2021012392
PROVIDER: scopus
PMCID: PMC8617436
PUBMED: 34499715
DOI/URL:
Notes: Letter -- Export Date: 1 December 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kevin Joseph Curran
    144 Curran